Related Experiment Videos
[Infantile spasms and West syndrome]
Georgeta Diaconu1, Ioana Grigore
1Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi, Facultatea de Medicină, 1 Clinica a III-a Pediatrie.
Summary
West syndrome is a severe infant epilepsy characterized by spasms and developmental issues. While difficult to treat, ACTH or corticosteroids are the preferred therapies, particularly for idiopathic cases.
Area of Science:
- Pediatric Neurology
- Epileptology
- Developmental Neuroscience
Context:
- West syndrome is a severe epileptic encephalopathy affecting infants and young children.
- It presents with a characteristic triad: infantile spasms, psychomotor development arrest/regression, and hypsarrhythmia on EEG.
- Onset typically occurs within the first year of life.
Purpose:
- To summarize the key features and current treatment consensus for West syndrome.
- To highlight the efficacy of specific treatments for this challenging condition.
Summary:
- West syndrome involves infantile spasms, developmental delays, and hypsarrhythmia, often beginning in the first year.
- Treatment is challenging, with Valproic acid (VPA) and benzodiazepines offering some benefit.
- Adrenocorticotropic hormone (ACTH) or oral corticosteroids are considered the primary treatment, especially for idiopathic West syndrome, which carries a better prognosis.
Impact:
- Provides a concise overview of West syndrome for clinicians and researchers.
- Reinforces the current treatment standards for managing this pediatric epilepsy.
- Emphasizes the importance of early diagnosis and appropriate therapeutic intervention for improved outcomes.